Exhibit 10.3


 


NEITHER THIS SECURITY NOR ANY SECURITIES INTO WHICH THIS SECURITY IS
EXERCISABLE HAS BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION
OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS
FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND SUCH
OTHER LAWS AND REQUIREMENTS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR LISTING OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH
REGISTRATION AND/OR LISTING REQUIREMENTS AS EVIDENCED BY A LEGAL OPINION OF
COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY
ACCEPTABLE TO THE COMPANY.


 





 


VUBOTICS, INC.


 


COMMON STOCK PURCHASE WARRANT


 


 




	
  Warrant Shares:                

  	
   

  	
  Initial
  Exercise Date:                 ,
  2007

  






 


                THIS COMMON STOCK
PURCHASE WARRANT (the “Warrant”) certifies that, for value received,                 ,
a                
(the “Holder”), is entitled, upon the terms and conditions herein, at any time
on or after the date hereof (the “Initial Exercise Date”) and on or prior to
the close of business on                 ,
2012 (the “Termination Date”), to subscribe for and purchase from VuBotics,
Inc., a Georgia corporation (the “Company”), up to                 
shares (the “Warrant Shares”) of common stock, par value $0.001 per share, of
the Company (the “Common Stock”). The purchase price of each share of Common
Stock under this Warrant will be equal to the Exercise Price as set forth in
Section 2(b).


 


Section
1.               Definitions.
Capitalized terms used and not defined herein will have the respective meanings
as set forth in that certain Securities Purchase Agreement (the “Purchase
Agreement”), dated August 28, 2007, by and between the Company, Holder and
certain other parties.


Section
2.               Exercise.


(a)           Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may
be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company
of a duly 


 

















 


executed facsimile copy of
the Notice of Exercise Form attached as Exhibit A; and, within three (3)
Trading Days of the date said Notice of Exercise is delivered to the Company,
Holder will forward payment of the aggregate Exercise Price of the shares
thereby purchased by wire transfer. Each exercise of this Warrant  will be for a whole number of shares.  Holder will not be required to physically
surrender this Warrant to the Company until Holder has purchased all of the
Warrant Shares and the Warrant has been exercised in full, in which case,
Holder will surrender this Warrant to the Company for cancellation within three
(3) Trading Days of the date the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares will have the effect of reducing the
number of Warrant Shares purchasable thereafter in an amount equal to the
number of Warrant Shares purchased. The Company will maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The
Company will deliver any objection to any Notice of Exercise Form within two
(2) Business Days of receipt of such notice. “Business Day” means any day
except Saturday, Sunday, any day which will be a federal legal holiday in the
United States or any day on which banking institutions in the State of New York
are authorized or required by law or other governmental action to close. Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that
following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be
less than the amount stated on the face hereof.


(b)           Exercise Price. The exercise
price per share of the Common Stock under this Warrant will be Twenty Cents
($0.20), subject to adjustment hereunder (the “Exercise Price”).


(c)           Mechanics of Exercise.


(i)            Form of Consideration.  The Warrant is exercisable, in whole or in
part, by either (a) delivery of the exercise price in cash or (b) the Holder’s
election of a cashless exercise, which will result in the Holder receiving that
number of shares of Common Stock equal to (X) the excess of the fair market
value per share (as determined by the volume weighted average price of the
Common Stock on the OTC Bulletin Board over any 10 consecutive trading days (“VWAP”)
over the exercise price per share on the date of exercise, multiplied by (Y)
the total number of shares as to which exercised, and then divided by (Z) the
VWAP.


(ii)           Authorization of Warrant Shares.
The Company covenants that all Warrant Shares which may be issued upon the
exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant (including payment for the
Warrant Shares), be duly authorized, validly issued, fully paid and
nonassessable and free from all taxes, liens and charges (other than taxes in
respect of any transfer occurring contemporaneously with such issue).


(iii)          Delivery
of Certificates Upon Exercise. Certificates for shares purchased hereunder
will be by physically delivery to the address specified by Holder in the Notice
of Exercise within three (3) Trading Days from the delivery to the Company of
the Notice of Exercise Form, surrender of this Warrant (if required) and
payment of the aggregate Exercise Price as set forth above (“Warrant Share
Delivery Date”). This Warrant will be deemed 


 


2

















 


to have been exercised on
the date the Exercise Price is received by the Company.  The Warrant Shares will be deemed to have
been issued, and Holder or any other person so designated to be named therein
will be deemed to have become a holder of record of such shares for all
purposes, as of the date the Warrant has been exercised by payment to the
Company of the Exercise Price and all taxes required to be paid by Holder, if
any, pursuant to Section 2(d)(vii) prior to the issuance of such shares, have
been paid.


(iv)          Delivery of New Warrants Upon
Exercise. If this Warrant is exercised in part, the Company will, at the
request of Holder and upon surrender of this Warrant certificate, at the time
of delivery of the certificate or certificates representing Warrant Shares,
deliver to Holder a new Warrant evidencing the rights of Holder to purchase the
un-purchased Warrant Shares called for by this Warrant, which new Warrant will
be identical with this Warrant.


(v)           No Fractional Shares or Scrip.
No fractional shares or scrip representing fractional shares will be issued
upon the exercise of this Warrant. As to any fraction of a share which Holder
would otherwise be entitled to, the Company will at its election, either pay a
cash adjustment in respect of such final fraction in an amount equal to such
fraction multiplied by the Exercise Price or round up to the next whole share.


(vi)          Charges, Taxes and Expenses.
Issuance of certificates for Warrant Shares will be made without charge to
Holder for any issue or transfer tax or other incidental expense in respect of
the issuance of such certificate, all of which taxes and expenses will be paid
by the Company, and such certificates will be issued in the name of Holder or
in such name or names as may be directed by Holder; however if certificates for
Warrant Shares are to be issued in a name other than the name of Holder, this
Warrant when surrendered for exercise will be accompanied by the Assignment
Form attached as Exhibit B duly executed by Holder; and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse
it for any transfer tax incidental thereto.


(vii)         Closing of Books. The Company
will not close its stockholder books or records in any manner which prevents
the timely exercise of this Warrant, pursuant to the terms hereof.


Section
3.               Adjustments.


(a)           If
the Company pays a dividend of Common Stock or makes a distribution in Common
Stock, subdivides its issued and outstanding Common Stock into a greater number
of shares, increases or decreases the number of shares of Common Stock
outstanding by reclassifying its Common Stock (whether through a recapitalization,
consolidation, merger or otherwise), then (a) the Exercise Price on the record
date of such division or distribution or the effective date of such action will
be adjusted by multiplying the Exercise Price by a fraction whose numerator is
the number of shares of Common Stock outstanding immediately before such event
and whose denominator is the number of shares of Common Stock outstanding
immediately after such event, and (b) the number of shares of Common Stock for
which this Warrant may be converted immediately before such event will be
adjusted by multiplying such number by a fraction, the numerator of which is
the number of 


 


3

















 


shares of Common Stock
outstanding immediately after such event and the denominator of which is the
number of shares of Common Stock outstanding immediately before such event


(b)           If the Company issues additional
Common Stock or other securities convertible into Common Stock or exercisable
to purchase Common Stock (other than (x) in a transaction for which an
adjustment is made pursuant to Section 3(a) hereof or (y) Common Stock (i)
options issued to any directors, officers or individual contractors of Issuer
as incentive compensation and any Common Stock issued upon exercise thereof,
(ii) issued for consideration other than cash pursuant to a merger,
consolidation, acquisition or similar business combination, (iii) issued in
exchange for services rendered to the Company, or (iv) with respect to which
the holders of Warrants representing a majority of the shares of Common Stock
issuable upon exercise thereof waive their anti-dilution rights under this
Section 3(b)) at a purchase price less than the $0.10 per share, then the
Exercise Price will be subject to a weighted average adjustment to reduce
dilution using the following formula:


NEP = OEP * ((CSO + CSP) / (CSO + CSAP)),
where


                                                NEP = new
Exercise Price; and


                                                OEP = old
Exercise Price; and


                                                CSO = shares of
Common Stock outstanding prior to the issuance of the securities triggering the
adjustment to the Exercise Price plus all shares of Common Stock issuable upon
exercise of all outstanding options, warrants, conversion rights and/or other
similar rights to acquire Common Stock, at an exercise or conversion price less
than or equal to the old Exercise Price, outstanding prior to the issuance of
the securities triggering the adjustment to the Exercise Price; and


CSP
= shares of Common Stock purchasable with consideration received by the Company
in the issuance of securities triggering the adjustment to the Exercise Price
had such securities reflected a per share price for Common Stock that was the
same as the old Exercise Price; and


CSAP
= shares of Common Stock actually purchased, or deemed purchased, in the
issuance of securities triggering the adjustment to the Exercise Price.


(c)           Calculations. All calculations
under this Section 3 will be made to the nearest cent or the nearest 1/100th of
a share, as the case may be. For purposes of this Section 3, the number of
shares of Common Stock deemed to be issued and outstanding as of a given date
will be the sum of the number of shares of Common Stock (excluding treasury
shares, if any) issued and outstanding.


(d)           Notice to Holder.


(i)            Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any
provision of this Section 3, the Company will promptly mail to Holder a notice
setting forth the Exercise Price after such adjustment and setting forth a
brief statement of the facts requiring such adjustment.


 


4

















 


Section
4.                                            Transfer of
Warrant.


(a)           Transferability. Subject to
compliance with any applicable securities laws and the conditions set forth in
Section 4(d) hereof, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant
substantially in the form attached hereto duly executed by Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the
making of such transfer. Upon such surrender and, if required, such payment,
the Company will execute and deliver a new Warrant or Warrants in the name of
the assignee or assignees and in the denomination or denominations specified in
such instrument of assignment, and will issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant will
promptly be cancelled. A Warrant, if properly assigned, may be exercised by a
new holder for the purchase of Warrant Shares without having a new Warrant
issued.


(b)           New Warrants. This Warrant may
be divided or combined with other Warrants upon presentation hereof at the
aforesaid office of the Company, together with a written notice specifying the
names and denominations in which new Warrants are to be issued, signed by
Holder or its agent or attorney. Subject to compliance with Section 4(a), as to
any transfer which may be involved in such division or combination, the Company
will execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice.


(c)           Warrant Register. The Company
will register this Warrant, upon records to be maintained by the Company for
that purpose (the “Warrant Register”), in the name of the record Holder hereof
from time to time. The Company may deem and treat the registered Holder of this
Warrant as the absolute owner hereof for the purpose of any exercise hereof or
any distribution to Holder, and for all other purposes, absent actual notice to
the contrary.


(d)           Transfer Restrictions. If, at
the time of the surrender of this Warrant in connection with any transfer of
this Warrant, the transfer of this Warrant will not be registered pursuant to
an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws, the Company may require, as a
condition of allowing such transfer, that (i) Holder or transferee of this
Warrant, as the case may be, furnish to the Company a written opinion of
counsel (which opinion will be in form, substance and scope customary for
opinions of counsel in comparable transactions) to the effect that such
transfer may be made without registration under the Securities Act and under
applicable state securities or blue sky laws and (ii) Holder or transferee
execute and deliver to the Company an investment letter in form and substance
acceptable to the Company and a fully completed investor questionnaire in the
form of Exhibit F to the Purchase Agreement.


Section
5.                                            Registration
Rights.  The Common Stock issuable upon
exercise of this Warrant is subject to registration pursuant to a Registration
Rights Agreement, dated as of the date hereof among the Company, the placement
agents for the securities contemplated under the Purchase Agreement, Holder and
the other purchasers under the Purchase Agreement.


 


5

















 


 


[The following clause is optional at the
request of the Purchaser of this Warrant, with the choice between 4.99% and
9.99% being at the option of the Purchaser.]


 


Section 6.                                            Limitation on
Beneficial Ownership.   The Company
will not effect and will have no obligation to effect any exercise of this
Warrant, and the Holder will have no right to convert any portion of this Note,
to the extent that after giving effect to such conversion, the beneficial owner
of such shares (together with such person’s affiliates) would have acquired,
through exercise of this Warrant or otherwise, beneficial ownership of a number
of shares of Common Stock that exceeds [4.99% / 9.99%] (“Maximum Percentage”) of the number of
shares of Common Stock outstanding immediately after giving effect to such
conversion.    For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by a person and its
affiliates shall include the number of shares of Common Stock issuable upon exercise
of this Warrant with respect to which the determination of such sentence is
being made, but shall exclude the number of shares of Common Stock which would
be issuable upon (A) exercise of the remaining, non-exercised portion of this
Warrant beneficially owned by such person or any of its affiliates and (B)
exercise or conversion of the unexercised or unconverted portion of any other
securities of the Company (including, without limitation, the Notes) subject to
a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by such person or any of its affiliates.  Except
as set forth in the preceding sentence, for purposes of this Section 6,
beneficial ownership will be calculated in accordance with Section 13(d) of the
Exchange Act.  For purposes of this Section 6, in determining the number
of outstanding shares of Common Stock, a Holder may rely on the number of
shares of outstanding Common Stock as reflected in (1) the Company’s most
recent Form 8-K, Form 10-Q, Form 10-QSB, Form 10-K or Form 10-KSB as the case
may be, (2) a more recent public announcement by the Company, or (3) any other
notice by the Company or its transfer agent setting forth the number of shares
of Common Stock outstanding.  Upon the written request of any Holder, the
Company will promptly, but in no event later than 2 business days following the
receipt of such notice, confirm orally and in writing to any such Holder the
number of shares of Common Stock then outstanding.  In any case, the
number of outstanding shares of Common Stock will be determined after giving
effect to conversions of preferred shares by such Holder and its affiliates
since the date as of which such number of outstanding Common Stock was
reported.  By written notice to the Company, the Holder may increase or
decrease the Maximum Percentage to any other percentage not in excess of  [4.99% / 9.99%] specified in such notice, but
(i) any such increase will not be effective until the sixty-first (61st) day
after such notice is delivered to the Company, and (ii) any such increase or
decrease will apply only to the Holder and not to any other Holder.


Section
7.                                            Miscellaneous.


(a)           No Rights as Shareholder Until
Exercise. This Warrant does not entitle Holder to any voting rights or
other rights as a shareholder of the Company prior to the exercise hereof as
set forth in Section 2(d)(ii).


(b)           Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that
upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of
indemnity or security reasonably satisfactory 


 


6

















 


to it (which, in the case of
the Warrant, will not include the posting of any bond), and upon surrender and
cancellation of such Warrant or stock certificate, if mutilated, the Company
will make and deliver a new Warrant or stock certificate of like tenor and dated
as of such cancellation, in lieu of such Warrant or stock certificate.


(c)           Saturdays, Sundays, Holidays, etc.
If the last or appointed day for the taking of any action or the expiration of
any right required or granted herein will not be a Business Day, then such
action may be taken or such right may be exercised on the next succeeding
Business Day.


(d)           Authorized Shares.


                The Company
covenants that during the period the Warrant is outstanding, it will reserve
from its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any
purchase rights under this Warrant. The Company further covenants that its
issuance of this Warrant will constitute full authority to its officers who are
charged with the duty of executing stock certificates to execute and issue the
necessary certificates for the Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such reasonable action as
may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any
requirements of any stock exchange or quotation service upon which the Common
Stock is traded, listed or quoted at such time.


 


                Except and to the
extent as waived or consented to by Holder, the Company will not by any action,
including, without limitation, amending its certificate of incorporation or
through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all
such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant
against impairment. Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase
in par value, (b) take all such action as may be necessary or appropriate in
order that the Company may validly and legally issue fully paid and
nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use
commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof as may
be necessary to enable the Company to perform its obligations under this
Warrant.


 


                Before taking any
action which would result in an adjustment in the number of Warrant Shares for
which this Warrant is exercisable or in the Exercise Price, the Company will
obtain all such authorizations or exemptions thereof, or consents thereto, as
may be necessary from any public regulatory body or bodies having jurisdiction
thereof.


 


(e)           Jurisdiction.
All questions concerning the construction, validity, enforcement and
interpretation of this Warrant will be determined in accordance with the
provisions of the Purchase Agreement.


 


7

















 


(f)            Restrictions. Holder
acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws.


(g)           Nonwaiver and Expenses. No
course of dealing or any delay or failure to exercise any right hereunder on
the part of Holder will operate as a waiver of such right or otherwise prejudice
Holder’s rights, powers or remedies, notwithstanding the fact that all rights
hereunder terminate on the Termination Date. If the Company willfully and
knowingly fails to comply with any provision of this Warrant, which results in
any material damages to Holder, the Company will pay to Holder such amounts as
will be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by Holder in collecting any amounts due pursuant hereto or in
otherwise enforcing any of its rights, powers or remedies hereunder.


(h)           Notices. Any notice, request
or other document required or permitted to be given or delivered to Holder by
the Company will be delivered in accordance with the notice provisions of the
Purchase Agreement.


(i)            Limitation of Liability. No
provision hereof, in the absence of any affirmative action by Holder to
exercise this Warrant to purchase Warrant Shares, and no enumeration herein of
the rights or privileges of Holder, will give rise to any liability of Holder
for the purchase price of any Common Stock or as a stockholder of the Company,
whether such liability is asserted by the Company or by creditors of the
Company.


(j)            Remedies. Holder, in addition
to being entitled to exercise all rights granted by law, including recovery of
damages, will be entitled to specific performance of its rights under this
Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the
provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be
adequate.


(k)           Successors and Assigns.
Subject to applicable securities laws, this Warrant and the rights and
obligations evidenced hereby will inure to the benefit of and be binding upon
the successors of the Company and the successors and permitted assigns of
Holder. The provisions of this Warrant are intended to be for the benefit of
all Holders from time to time of this Warrant and will be enforceable by any
such Holder or holder of Warrant Shares.


(l)            Amendment. This Warrant may
be modified or amended or the provisions hereof waived with the written consent
of the Company and Holder.


(m)          Severability. Wherever
possible, each provision of this Warrant will be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant will be prohibited by or invalid under applicable law, such provision
will be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant.


(n)           Headings.
The headings used in this Warrant are for the convenience of reference only and
will not, for any purpose, be deemed a part of this Warrant.


 


8

















 


[signatures for Purchase Warrant]


 


SIGNED, SEALED AND DELIVERED as of the date first above
written.


 


	
   

  	
  VUBOTICS, INC.

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:
  Philip E. Lundquist

  
	
   

  	
  Title: Chief Executive
  Officer

  



 


9

















 


EXHIBIT A


 


NOTICE OF EXERCISE


 


 


TO:
[               


 


 


                                                (1) The
undersigned hereby elects to purchase                
Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price
in full, together with all applicable transfer taxes, if any.


 


                                                (2) Payment
will be in lawful money of the United States.


 


                                                (3) Please
issue a certificate or certificates representing said Warrant Shares in the
name of the undersigned or in such other name as is specified below:


 


	
   

  	
   

  



 


The Warrant Shares will be delivered by physical delivery of a
certificate to:


 


	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  



 


                                                (4) Accredited
Investor. The undersigned is an “accredited investor” as defined in Regulation
D promulgated under the Securities Act of 1933, as amended.


 


[SIGNATURE OF HOLDER]


 


	
  Name of Investing Entity:

  	
   

  
	
  Signature of Authorized
  Signatory of Investing Entity:

  	
   

  
	
  Name of Authorized
  Signatory:

  	
   

  
	
  Title of Authorized
  Signatory:

  	
   

  
	
  Date:

  	
   

  
						



 


10

















 


EXHIBIT B


 


ASSIGNMENT FORM


 


(To assign the foregoing warrant, execute


this form and supply required information.


Do not use this form to exercise the warrant.)


 


                FOR VALUE
RECEIVED, [          ] all of
or [               ]
shares of the foregoing Warrant and all rights evidenced thereby are hereby
assigned to                                              
whose address is                                                                                           .


 


	
  Dated:

  	
   

  	
  ,

  	
   

  	
   

  
	
   

  	
   

  
	
  Holder’s Signature: 

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Holder’s Address:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Signature Guaranteed:

  	
   

  	
   

  
											



 


NOTE: The signature to this Assignment Form must correspond with the
name as it appears on the face of the Warrant, without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank or trust
company. Officers of corporations and those acting in a fiduciary or other
representative capacity should file proper evidence of authority to assign the
foregoing Warrant.


 


11